Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov62910.25208/vdv629ArticlesСтатьиResearch ArticleSystemic antibiotics therapy of acne: certain controversiesСистемная антибиотикотерапия акне: некоторые дискуссионные вопросыARAVIYSKAYAYE RАРАВИЙСКАЯЕ Р

д.м.н., профессор кафедры дерматовенерологии с клиникой

arelenar@mail.ruSOKOLOVSKYYE VСОКОЛОВСКИЙЕ В

д.м.н., профессор, зав. кафедрой с клиникой

Pavlov State Medical University ot St. PeterburgГБОУ ВПО «Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова» Минздрава России15122013896NO6 (2013)№6 (2013)11712111032020Copyright ©; 2013, ARAVIYSKAYA Y.R., SOKOLOVSKY Y.V.Copyright ©; 2013, АРАВИЙСКАЯ Е.Р., СОКОЛОВСКИЙ Е.В.2013ARAVIYSKAYA Y.R., SOKOLOVSKY Y.V.АРАВИЙСКАЯ Е.Р., СОКОЛОВСКИЙ Е.В.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/629

The article presents intormation about systemic antibiotics treatment ot acne. The authors discuss issues such as indications tor the administration ot antibiotics, drug selection and combination with external drugs.

Приводятся сведения о системной антибактериальной терапии акне. Обсуждаются вопросы показаний для назначения антибиотиков, выбора препарата и сочетания с наружными средствами.

tetracyclinesdoxycyclineminocyclineantibiotic resistancecombination therapyтетрациклиныдоксициклинминоциклинантибиотикорезистентностькомбинированная терапияThiboutot D., Gollnick H.P., Bettoli V., Dreno B. et al. New insights into the management of acne: An update from the Global Alliacne to improve outcomes in acne group. JAAD 2009; 60: 5: 1—50Аравийская Е.Р., Красносельских Т.В., Соколовский Е.В. Акне. Кожный зуд. Акне. Урогенитальная хламидийная инфекция. Под ред. Е.В. Соколовского. СПб: Сотис, 1998; 68—110Самцов А.В. Акне и акнеформные дерматозы. Монография. М: OOO «ЮТКОМ» 2009; 208Jeremy A.H., Holland D.B., Roberts S.G., Thomson K.F., Cunliffe W.J. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 Jul; 121(1): 20—7.Brown S.K., Shalita A.R. Acne vulgaris. Lancet 1998; 351: 1871—1876.Cunliffe W.J. Acne. London: Martin Dunitz 1988; 392.Sapadin A.N., Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54(2): 258—65.Kim J., Ochoa M.T., Krutzik S.R., Takeuchi O. et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169(3): 1535—1541.Webster G.F., Graber E.M. Antibiotic treatment for acne vulgaris. Semin Cutan Med Surg 2008; 27(3): 183—187.Thielitz A., Gollnick H. Overview of new therapeutic developments for acne. Exp Rev Dermatol 2009; 4: 1: 55—65.Juhlin L. Lidén S. A quantitative evaluation of the effect of oxytetracycline and doxycycline in acne vulgaris. Br J Dermatol 1969; 81(2): 154—158.Maibach H. Lebrun-Vignes Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 1991; 48(5): 411—417.Kircik L.H. Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications. J Drugs Dermatol 2010; 9(11): 1407—1411.Lebrun-Vignes B., Kreft-Jais C., Castot A., Chosidow O. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. BJD 2012; 166: 1333—1341.Amin K., Riddle C.C., Aires D.J., Schweiger E.S. Common and alternate oral antibiotic therapies for acne vulgaris: a review. J Drugs Dermatol 2007; 6(9): 873—880.Bundino S., Salomone R., Zina A.M. Clinical evaluation of josamycin in the treatment of acne. G Ital Dermatol Venereol 1989; Nov—Dec: 11—12.Kus S., Yucelten D., Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol 2005; 30(3): 215—220.Kubanova A.A. Acne. Clinical Guidelines.M: DEKS-PRESS 2010 [Клинические рекомендации по ведению больных акне. Под ред. А.А. Кубановой. М: ДЭСК-ПРЕСС 2010.]Iinuma K., Noguchi N., Nakaminami H., Sasatsu M., Nishijima S., Tsuboi I. Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics. Clin Cosmet Investig Dermatol 2011; 4: 161—165.Krautheim A., Gollnick H.P. Acne: topical treatment. Clin Dermatol 2004; 22(5): 398—407.Oprica C., Nord C.E. Bacteria ESGoARiA. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005; 11: 204—213.Nishijima S., Kurokawa I., Kawabata S. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. J Int Med Res 1996; 24: 473—477.Ishida N., Nakaminami H., Noguchi N., Kurokawa I. et al. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008; 52: 621—624.Schafer F., Fich F., Lam M., Garate C., Wozniak A., Garcia P. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Int J Dermatol 2013; 52(4): 418—425.Cooper A. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aus 1998; 169: 259—261.Ross J., Snelling A., Carnegie E. et al. Clinical and laboratory investigations antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467—478.Nast A., Dreno B., Bettoli V., Degitz K. et al. European evidence-based (S3) guidelines for the treatment of acne. JEADV 2012; 26; 1: 1—29.Burke B., Eady E.A., Cunliffe W.J. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Brit J Dermatol 1983; 108: 199—204.Eady E.A., Farmery M.R., Ross J.I., Cove J.H., Cunliffe W.J. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Brit J Dermatol 1994; 131: 331—336.Gollnick H.P., Graupe K., Zaumseil R.P. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538—544.Feldman S.R., Tan J., Poulin Y., Dirschka T. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. JAAD, article in press: 10.1016/j.jaad.2010.03.036 (published online March 23, 2011).Feucht C.L., Allen B.S., Chalker D.K., Smith J.G.Jr. Topical erythromycin with zinc in acne. A double-blind controlled study. JAAD 1980; 3: 5: 483—491.Gollnick H.P., Draelos Z., Glenn M.J., Rosoph L.A. et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009; 161: 5: 1180—1189.Habbema L., Koopmans B., Menke H.E., Doornweerd S., De Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol 1989; 121: 4: 497—502.Leyden J. et al. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study. Am J Clin Dermatol 2001; 2: 263—266.Leyden J., Preston N., Osborn C., Gottschalk R.W. In-vivo effectiveness of adapalene 0.1%/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant propionibacterium acnes. Clin Aesthet Dermatol 2011; 4: 5: 22—26.Stein Gold L., Cruz A., Eichenfield L., Tan J. et al. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, doubleblind study of adapalene 0.1 %-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Cutis 2010; 85: 94—104.